GH Research PLC Ordinary Shares

GHRSNASDAQUSD
21.43 USD
1.82 (7.83%)AT CLOSE (11:59 AM EDT)
21.43
0.01 (0.02%)
POST MARKET (AS OF 07:34 PM EDT)
Post Market
AS OF 07:34 PM EDT
21.43
0.01 (0.02%)
🔴Market: CLOSED
Open?$23.01
High?$23.61
Low?$21.21
Prev. Close?$23.25
Volume?352.0K
Avg. Volume?N/A
VWAP?$21.90
Bid / Ask
Bid?$18.39 × 100
Ask?$25.46 × 100
Spread?$7.07
Midpoint?$21.93
Valuation & Ratios
Market Cap?1.5B
Shares Out?68.6M
Float?45.2M
Float %?72.9%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A

GH Research PLC Ordinary Shares (GHRS) trades at $21.43 per share. Our models show a "Sell" technical signal alongside a "Neutral" fundamental rating. This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9 and a bullish Golden Cross on the moving averages.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
Employees
73
Market Cap
1.5B
Industry
N/A
Listed
2021-06-25
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Neutral(0/3)
Medium-Term (Wave)? Neutral(0/3)
Short-Term (Ripple)? Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
50
Short Sent.?
56
Piotroski F-Score?0/9Weak
Altman Z-Score?185.62Safe
Confidence?31%Very Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?4.63%Low
Short Interest?2.1M
Days to Cover?12.4
Free Float45.2M
Avg Daily Volume169.1K
Settlement Date2026-05-15